Imdur and Muscle function loss - a phase IV clinical study of FDA data

Summary:

Muscle function loss is reported as a side effect among people who take Imdur (isosorbide mononitrate), especially for people who are female, 60+ old, also take Prevacid, and have Anaemia.

The phase IV clinical study analyzes which people have Muscle function loss when taking Imdur. It is created by eHealthMe based on reports of 17,119 people who have side effects when taking Imdur from the FDA, and is updated regularly.

What is Imdur?

Imdur has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 17,367 Imdur users. Check the latest studies of Imdur.

What is Muscle function loss?

Muscle function loss is found to be associated with 1,000 drugs and 1,520 conditions by eHealthMe. Check the latest studies of Muscle function loss.

On Jul, 21, 2026

17,119 people reported to have side effects when taking Imdur.
Among them, 15 people (0.09%) have Muscle function loss.

Among these 15 people:

What is the gender of people who have Muscle function loss when taking Imdur? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Muscle function loss when taking Imdur? *

What are other drugs people take besides Imdur? *

What are other side effects people have besides Muscle function loss? *

Weakness: 8 people, 53.33%
Pain: 7 people, 46.67%
Chest Pain: 5 people, 33.33%
Oedema Peripheral (superficial swelling): 5 people, 33.33%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 33.33%
Stress And Anxiety: 5 people, 33.33%
Joint Stiffness: 4 people, 26.67%
Pain Of Skin: 4 people, 26.67%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 4 people, 26.67%
Mobility Decreased (ability to move is reduced): 4 people, 26.67%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 4 people, 26.67%
Diabetes: 4 people, 26.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 26.67%
Anaemia (lack of blood): 4 people, 26.67%
Type 2 Diabetes: 1 person, 6.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.67%
Pain: 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 6.67%
Cerebral Haemorrhage (bleeding within the brain): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Imdur and have Muscle function loss?

- Check whether Muscle function loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imdur:

Imdur (17,367 reports)

Browse all side effects of Imdur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Muscle function loss:

Muscle function loss (1,000 drugs)

Browse all the conditions that are associated with Muscle function loss:

Muscle function loss (1,520 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Imdur) and Imdur (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.